Sensei Biotherapeutics Appoints New Financial Chief

Sensei Biotherapeutics ( (SNSE) ) just unveiled an announcement.

Sensei Biotherapeutics, Inc. recently appointed Josiah Craver as their new principal financial officer and principal accounting officer. Craver, bringing in a wealth of experience from KALA BIO and Solid Biosciences, is set to receive a $360,000 base salary, with a 35% annual bonus target and an option to purchase 80,000 company shares. His employment package includes financial safeguards such as a six-month base salary as severance and COBRA reimbursements, with additional benefits in the event of termination following a company change in control. This strategic move aims to bolster the financial leadership within Sensei Biotherapeutics, signaling potential growth and stability for investors.

Learn more about SNSE stock on TipRanks’ Stock Analysis page.